Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1985 Oct;78(10):844–848. doi: 10.1177/014107688507801011

New properties and roles for eosinophils in disease: discussion paper.

C J Spry
PMCID: PMC1289951  PMID: 3900398

Full text

PDF
844

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basran G. S., Page C. P., Paul W., Morley J. Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy. 1984 Jan;14(1):75–79. doi: 10.1111/j.1365-2222.1984.tb02193.x. [DOI] [PubMed] [Google Scholar]
  2. Bass D. A., Grover W. H., Lewis J. C., DeChatelet L. R., McCall C. E. Stimulation or activation of eosinophils in vivo during eosinophilia: possible role of arachidonic acid metabolism. Adv Exp Med Biol. 1982;141:509–518. doi: 10.1007/978-1-4684-8088-7_49. [DOI] [PubMed] [Google Scholar]
  3. Basten A., Beeson P. B. Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med. 1970 Jun 1;131(6):1288–1305. doi: 10.1084/jem.131.6.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beeson P. B., Bass D. A. The eosinophil. Major Probl Intern Med. 1977;14:1–269. [PubMed] [Google Scholar]
  5. Davies J., Spry C. J., Sapsford R., Olsen E. G., de Perez G., Oakley C. M., Goodwin J. F. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med. 1983 Winter;52(205):23–39. [PubMed] [Google Scholar]
  6. Dessein A. J., Vadas M. A., Nicola N. A., Metcalf D., David J. R. Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med. 1982 Jul 1;156(1):90–103. doi: 10.1084/jem.156.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flaum M. A., Schooley R. T., Fauci A. S., Gralnick H. R. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood. 1981 Nov;58(5):1012–1020. [PubMed] [Google Scholar]
  8. Gleich G. J., Loegering D. A., Adolphson C. R. Eosinophils and bronchial inflammation. Chest. 1985 Jan;87(1 Suppl):10S–13S. doi: 10.1378/chest.87.1_supplement.10s. [DOI] [PubMed] [Google Scholar]
  9. Gleich G. J., Loegering D. A. Immunobiology of eosinophils. Annu Rev Immunol. 1984;2:429–459. doi: 10.1146/annurev.iy.02.040184.002241. [DOI] [PubMed] [Google Scholar]
  10. Henderson W. R., Harley J. B., Fauci A. S. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. Immunology. 1984 Apr;51(4):679–686. [PMC free article] [PubMed] [Google Scholar]
  11. Hällgren R., Venge P., Cullhed I., Olsson I. Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration. Br J Haematol. 1979 May;42(1):147–154. doi: 10.1111/j.1365-2141.1979.tb03707.x. [DOI] [PubMed] [Google Scholar]
  12. Khalife J., Capron M., Grzych J. M., Bazin H., Capron A. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins. J Immunol. 1985 Mar;134(3):1968–1974. [PubMed] [Google Scholar]
  13. Lee T., Lenihan D. J., Malone B., Roddy L. L., Wasserman S. I. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem. 1984 May 10;259(9):5526–5530. [PubMed] [Google Scholar]
  14. Lotze M. T., Robb R. J., Sharrow S. O., Frana L. W., Rosenberg S. A. Systemic administration of interleukin-2 in humans. J Biol Response Mod. 1984 Oct;3(5):475–482. [PubMed] [Google Scholar]
  15. López A. F., Vadas M. A. Stimulation of human granulocyte function by monoclonal antibody WEM-G1. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1818–1821. doi: 10.1073/pnas.81.6.1818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moore P. M., Harley J. B., Fauci A. S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1985 Jan;102(1):109–114. doi: 10.7326/0003-4819-102-1-109. [DOI] [PubMed] [Google Scholar]
  17. Olsen E. G., Spry C. J. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis. 1985 Jan-Feb;27(4):241–254. doi: 10.1016/0033-0620(85)90008-8. [DOI] [PubMed] [Google Scholar]
  18. Prin L., Capron M., Tonnel A. B., Bletry O., Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol. 1983;72(4):336–346. doi: 10.1159/000234893. [DOI] [PubMed] [Google Scholar]
  19. Schooley R. T., Flaum M. A., Gralnick H. R., Fauci A. S. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood. 1981 Nov;58(5):1021–1026. [PubMed] [Google Scholar]
  20. Slungaard A., Ascensao J., Zanjani E., Jacob H. S. Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med. 1983 Sep 29;309(13):778–781. doi: 10.1056/NEJM198309293091307. [DOI] [PubMed] [Google Scholar]
  21. Spry C. J., Davies J., Tai P. C., Olsen E. G., Oakley C. M., Goodwin J. F. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med. 1983 Winter;52(205):1–22. [PubMed] [Google Scholar]
  22. Spry C. J., Tai P. C., Barkans J. Tissue localization of human eosinophil cationic proteins in allergic diseases. Int Arch Allergy Appl Immunol. 1985;77(1-2):252–254. doi: 10.1159/000233803. [DOI] [PubMed] [Google Scholar]
  23. Spry C. J., Tai P. C. Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol. 1976 Jun;24(3):423–434. [PMC free article] [PubMed] [Google Scholar]
  24. Spry C. J. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982 Nov;37(8):539–551. doi: 10.1111/j.1398-9995.1982.tb02339.x. [DOI] [PubMed] [Google Scholar]
  25. Sun X. H., Davis W. B., Fukuda Y., Ferrans V. J., Crystal R. G. Experimental polymyxin B-induced interstitial lung disease characterized by an accumulation of cytotoxic eosinophils in the alveolar structures. Am Rev Respir Dis. 1985 Jan;131(1):103–108. doi: 10.1164/arrd.1985.131.1.103. [DOI] [PubMed] [Google Scholar]
  26. Tai P. C., Bakes D. M., Barkans J. R., Spry C. J. Plasma membrane antigens on light density and activated human blood eosinophils. Clin Exp Immunol. 1985 May;60(2):427–436. [PMC free article] [PubMed] [Google Scholar]
  27. Tai P. C., Hayes D. J., Clark J. B., Spry C. J. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J. 1982 Apr 15;204(1):75–80. doi: 10.1042/bj2040075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tai P. C., Holt M. E., Denny P., Gibbs A. R., Williams B. D., Spry C. J. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) 1984 Aug 18;289(6442):400–402. doi: 10.1136/bmj.289.6442.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tai P. C., Spry C. J. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA). Clin Exp Immunol. 1980 Apr;40(1):206–219. [PMC free article] [PubMed] [Google Scholar]
  30. Tai P. C., Spry C. J., Peterson C., Venge P., Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 1984 May 10;309(5964):182–184. doi: 10.1038/309182a0. [DOI] [PubMed] [Google Scholar]
  31. Vadas M. A. Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens. J Immunol. 1981 Nov;127(5):2083–2086. [PubMed] [Google Scholar]
  32. Vadas M. A. Genetic control of eosinophilia in mice: gene(s) expressed in bone marrow-derived cells control high responsiveness. J Immunol. 1982 Feb;128(2):691–695. [PubMed] [Google Scholar]
  33. Vadas M. A., Nicola N., Lopez A. F., Metcalf D., Johnson G., Pereira A. Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol. 1984 Jul;133(1):202–207. [PubMed] [Google Scholar]
  34. Veith M., Taylor D. W., Thorne K., Richardson B. A., Butterworth A. E. Studies on the enhancement of human eosinophil function by mononuclear cell products in vitro. Clin Exp Immunol. 1984 Dec;58(3):603–610. [PMC free article] [PubMed] [Google Scholar]
  35. Warren D. J., Sanderson C. J. Production of a T-cell hybrid producing a lymphokine stimulating eosinophil differentiation. Immunology. 1985 Apr;54(4):615–623. [PMC free article] [PubMed] [Google Scholar]
  36. Weller P. F., Bach D. S., Austen K. F. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem. 1984 Dec 25;259(24):15100–15105. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES